Adverum Biotechnologies
Pre-clinicalAt Adverum, we are driven to establish ocular gene therapy as a new standard of care for debilitating retinal diseases.
Founded
2006
Focus
Drug DeliveryRNA & Gene TherapyCell & Gene Therapy
About
At Adverum, we are driven to establish ocular gene therapy as a new standard of care for debilitating retinal diseases.
Funding History
4Total raised: $304.5M
PIPE$129.5MRA Capital ManagementJul 15, 2020
Series B$60MRedmile GroupJun 15, 2015
IPO$75MUndisclosedJul 15, 2014
Series A$40MThird Rock VenturesJan 15, 2014
Company Info
TypePrivate
Founded2006
LocationRedwood City, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile